Study status

As of 31st October, 738 patients are enrolled in PROMETCO and there are 96 recruiting investigational sites in 18 countries.

18

Participating
countries

98

Investigational sites

96 recruiting

2 non-recruiting

Number of patients enrolled: 738

Target number of patients: 1000

Graph showing number of patients per country
as of October 31, 2022

ARG: Argentina, AUT: Austria, BEL: Belgium, CHE: Switzerland, CZE: Czech Republic, DEU: Germany, ESP: Spain, FRA: France, GRE: Greece, HRV: Croatia, HUN: Hungary, IRL: Ireland, ITA: Italy, NLD: Netherlands, PRT: Portugal, SVN: Slovenia, SWE: Sweden, UK: United Kingdom